Hecker L I
Chem Biol Interact. 1980 Apr;30(1):57-65. doi: 10.1016/0009-2797(80)90114-3.
N-Nitrosopyrrolidine is carcinogenic for the liver but not for the lung. Optimal conditions for the metabolism of N-nitrosopyrrolidine (NO-PYR) by rat lung microsomes and post-microsomal supernatant were determined. Neither lung nor liver subcellular fractions were able to form detectable amounts of 3-hydroxyNO-PYR. Liver and lung microsomes could only alpha-hydroxylate NO-PYR, and even though the rates of lung reactions were considerably slower than those of liver, similar products were produced by the action of both lung and liver supernatants on microsomal products. The apparent Km for the lung microsome plus supernatant reaction was approx. 20 mM as compared with 0.36 mM for the liver system. Since both the target and non-target tissue extracts could metabolize NO-PYR by the same pathways, we speculate that alpha-hydroxylation of NO-PYR may be a necessary, but not sufficient cause for its carcinogenic actions.
N-亚硝基吡咯烷对肝脏具有致癌性,但对肺没有致癌性。确定了大鼠肺微粒体和微粒体后上清液代谢N-亚硝基吡咯烷(NO-PYR)的最佳条件。肺和肝脏的亚细胞部分均无法形成可检测量的3-羟基NO-PYR。肝脏和肺微粒体只能将NO-PYR进行α-羟基化,尽管肺反应的速率比肝脏反应的速率慢得多,但肺和肝脏上清液对微粒体产物的作用产生了相似的产物。肺微粒体加上清液反应的表观Km约为20 mM,而肝脏系统为0.36 mM。由于靶组织和非靶组织提取物都可以通过相同的途径代谢NO-PYR,因此我们推测NO-PYR的α-羟基化可能是其致癌作用的必要但不充分的原因。